- Home
- ABCB vs MLTX Comparison
ABCB vs MLTX Comparison
Compare ABCB & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABCB
- MLTX
- Stock Information
- Founded
- ABCB 1971
- MLTX 2021
- Country
- ABCB United States
- MLTX Switzerland
- Employees
- ABCB N/A
- MLTX N/A
- Industry
- ABCB Major Banks
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- ABCB Finance
- MLTX Health Care
- Exchange
- ABCB Nasdaq
- MLTX Nasdaq
- Market Cap
- ABCB 4.4B
- MLTX 2.8B
- IPO Year
- ABCB N/A
- MLTX N/A
- Fundamental
- Price
- ABCB $67.53
- MLTX $49.00
- Analyst Decision
- ABCB Buy
- MLTX Strong Buy
- Analyst Count
- ABCB 6
- MLTX 7
- Target Price
- ABCB $69.83
- MLTX $73.33
- AVG Volume (30 Days)
- ABCB 354.1K
- MLTX 463.2K
- Earning Date
- ABCB 07-28-2025
- MLTX 08-06-2025
- Dividend Yield
- ABCB 1.19%
- MLTX N/A
- EPS Growth
- ABCB 31.20
- MLTX N/A
- EPS
- ABCB 5.38
- MLTX N/A
- Revenue
- ABCB $1,100,260,000.00
- MLTX N/A
- Revenue This Year
- ABCB $12.06
- MLTX $103.42
- Revenue Next Year
- ABCB $6.18
- MLTX N/A
- P/E Ratio
- ABCB $12.55
- MLTX N/A
- Revenue Growth
- ABCB 13.98
- MLTX N/A
- 52 Week Low
- ABCB $48.27
- MLTX $31.42
- 52 Week High
- ABCB $74.56
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- ABCB 70.26
- MLTX 63.01
- Support Level
- ABCB $66.92
- MLTX $46.37
- Resistance Level
- ABCB $68.10
- MLTX $49.29
- Average True Range (ATR)
- ABCB 1.32
- MLTX 1.85
- MACD
- ABCB 0.25
- MLTX 0.05
- Stochastic Oscillator
- ABCB 87.34
- MLTX 88.30
About ABCB Ameris Bancorp
Ameris Bancorp is a bank holding company that operates through Ameris Bank, its subsidiary. The company operates branches in Georgia, Alabama, Florida, and South Carolina. It offers traditional banking services such as business banking, personal banking, checking, savings, mobile banking, and others. The bank is organized into four segments: the Banking Division, the Retail Mortgage Division, the Warehouse Lending Division and the Premium Finance Division. The company generates majority of its revenue from the banking division. Ameris intends to acquire banks in its geographic region to increase its market share and expand beyond its current market.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.